CochLear Company Insiders
| CHEOY Stock | USD 97.60 1.46 1.52% |
CochLear employs about 4.5 K people. The company is managed by 10 executives with a total tenure of roughly 33 years, averaging almost 3.0 years of service per executive, having 450.0 employees per reported executive. Break down of CochLear's management performance can provide insight into the company performance.
| Stuart Sayers President President - Services |
| Anthony Bishop President President - Asia Pacific |
CochLear |
CochLear Management Team Effectiveness
The company has return on total asset (ROA) of 0.0973 % which means that it generated a profit of $0.0973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1713 %, meaning that it generated $0.1713 on every $100 dollars invested by stockholders. CochLear's management efficiency ratios could be used to measure how well CochLear manages its routine affairs as well as how well it operates its assets and liabilities.CochLear Workforce Comparison
CochLear Ltd ADR is rated below average in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 383,062. CochLear claims roughly 4,500 in number of employees contributing just under 2% to all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. CochLear ADR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. CochLear ADR Price Series Summation is a cross summation of CochLear price series and its benchmark/peer.
CochLear Notable Stakeholders
A CochLear stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CochLear often face trade-offs trying to please all of them. CochLear's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CochLear's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stuart Sayers | President - Services | Profile | |
| Anthony Bishop | President - Asia Pacific | Profile | |
| Dean Phizacklea | Senior Vice President Global Marketing | Profile | |
| David Hackshall | Chief Officer | Profile | |
| MBA BE | MD, CEO | Profile | |
| Richard MBA | Pres EMEA | Profile | |
| Jennifer Stevenson | VP Brand | Profile | |
| Jan Eng | Chief Officer | Profile | |
| Kristina Devon | VP Relations | Profile | |
| Lisa Aubert | Pres America | Profile |
About CochLear Management Performance
The success or failure of an entity such as CochLear ADR often depends on how effective the management is. CochLear management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CochLear management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CochLear management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company was founded in 1981 and is headquartered in Sydney, Australia. Cochlear operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4500 people.
Please note, the imprecision that can be found in CochLear's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CochLear Ltd ADR. Check CochLear's Beneish M Score to see the likelihood of CochLear's management manipulating its earnings.
CochLear Workforce Analysis
Traditionally, organizations such as CochLear use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CochLear within its industry.CochLear Manpower Efficiency
Return on CochLear Manpower
| Revenue Per Employee | 366.3K | |
| Revenue Per Executive | 164.8M | |
| Net Income Per Employee | 64.2K | |
| Net Income Per Executive | 28.9M | |
| Working Capital Per Employee | 64.9K | |
| Working Capital Per Executive | 29.2M |
Additional Tools for CochLear Pink Sheet Analysis
When running CochLear's price analysis, check to measure CochLear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CochLear is operating at the current time. Most of CochLear's value examination focuses on studying past and present price action to predict the probability of CochLear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CochLear's price. Additionally, you may evaluate how the addition of CochLear to your portfolios can decrease your overall portfolio volatility.